TrialBlood2018

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Alex F Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.